175 related articles for article (PubMed ID: 23295772)
1. Optic pathway gliomas in adolescence--time to challenge treatment choices?
Chong AL; Pole JD; Scheinemann K; Hukin J; Tabori U; Huang A; Bouffet E; Bartels U
Neuro Oncol; 2013 Mar; 15(3):391-400. PubMed ID: 23295772
[TBL] [Abstract][Full Text] [Related]
2. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
[TBL] [Abstract][Full Text] [Related]
3. The role of surgery in optic pathway/hypothalamic gliomas in children.
Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity.
Grabenbauer GG; Schuchardt U; Buchfelder M; Rödel CM; Gusek G; Marx M; Doerr HG; Fahlbusch R; Huk WJ; Wenzel D; Sauer R
Radiother Oncol; 2000 Mar; 54(3):239-45. PubMed ID: 10738082
[TBL] [Abstract][Full Text] [Related]
5. Optic glioma in children: a retrospective analysis of 101 cases.
Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
[TBL] [Abstract][Full Text] [Related]
6. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
[TBL] [Abstract][Full Text] [Related]
8. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.
Janss AJ; Grundy R; Cnaan A; Savino PJ; Packer RJ; Zackai EH; Goldwein JW; Sutton LN; Radcliffe J; Molloy PT
Cancer; 1995 Feb; 75(4):1051-9. PubMed ID: 7842408
[TBL] [Abstract][Full Text] [Related]
9. Natural history and outcome of optic pathway gliomas in children.
Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
[TBL] [Abstract][Full Text] [Related]
10. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
11. Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.
Peyrl A; Azizi A; Czech T; Gruber-Olipitz M; Jones N; Haberler C; Prayer D; Autzinger E; Slavc I
Pediatr Blood Cancer; 2009 Apr; 52(4):476-80. PubMed ID: 19061223
[TBL] [Abstract][Full Text] [Related]
12. Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases.
Jaing TH; Lin KL; Tsay PK; Hsueh C; Hung PC; Wu CT; Tseng CK
J Pediatr Hematol Oncol; 2008 Mar; 30(3):222-4. PubMed ID: 18376285
[TBL] [Abstract][Full Text] [Related]
13. Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy.
Erkal HS; Serin M; Cakmak A
Radiother Oncol; 1997 Oct; 45(1):11-5. PubMed ID: 9364626
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy for Optic Pathway and Hypothalamic Low-Grade Gliomas in Children.
Tsang DS; Murphy ES; Merchant TE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):642-651. PubMed ID: 29280458
[TBL] [Abstract][Full Text] [Related]
15. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
[TBL] [Abstract][Full Text] [Related]
16. Optic pathway glioma: outcome and prognostic factors in a surgical series.
Ahn Y; Cho BK; Kim SK; Chung YN; Lee CS; Kim IH; Yang SW; Kim HS; Kim HJ; Jung HW; Wang KC
Childs Nerv Syst; 2006 Sep; 22(9):1136-42. PubMed ID: 16628460
[TBL] [Abstract][Full Text] [Related]
17. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in children with gliomas of the anterior visual pathway.
Tow SL; Chandela S; Miller NR; Avellino AM
Pediatr Neurol; 2003 Apr; 28(4):262-70. PubMed ID: 12849878
[TBL] [Abstract][Full Text] [Related]
19. Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas.
Bartels U; Hawkins C; Jing M; Ho M; Dirks P; Rutka J; Stephens D; Bouffet E
J Neurosurg; 2006 May; 104(5 Suppl):314-20. PubMed ID: 16848088
[TBL] [Abstract][Full Text] [Related]
20. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
